September 2023
1. HASPEL RL, McKenna DH
   Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk.
   Br J Haematol. 2023 Sep 8. doi: 10.1111/bjh.19101.
   

   >> Share

   
   
2. JARISCH A, Bonig H
   Response to Haspel and McKenna 'Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk'.
   Br J Haematol. 2023 Sep 7. doi: 10.1111/bjh.19100.
   

   >> Share

   
   June 2023
3. JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
   Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
   Br J Haematol. 2023;201:1159-1168.
   

   >> Share

   
   March 2023
4. GAFFET M, Wiedemann A, Dalle JH, Bilger K, et al
   Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society for Bone Marrow Transplantation and Cell Therapy (SFG
   Br J Haematol. 2023 Mar 27. doi: 10.1111/bjh.18744.
   

   >> Share

   
   August 2022
5. KATO I, Sakaguchi H, Kato S, Sato M, et al
   Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.
   Br J Haematol. 2022 Aug 27. doi: 10.1111/bjh.18425.
   

   >> Share

   
   
6. WOLF J, Lee J, Pearce R, Wilson M, et al
   The impact of COVID-19 on related-donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey.
   Br J Haematol. 2022;198:e51-e53.
   

   >> Share

   
   July 2022
7. GHANDILI S, Kluger MA, Leitner T, Grahammer F, et al
   Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation.
   Br J Haematol. 2022;198:199-202.
   

   >> Share

   
   June 2022
8. MURRAY SM, Barbanti M, Campbell C, Brown A, et al
   Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than two years post allogeneic bone marrow transplant.
   Br J Haematol. 2022 Jun 2. doi: 10.1111/bjh.18312.
   

   >> Share

   
   February 2022
9. TAMEFUSA K, Ochi M, Fujiwara K, Washio K, et al
   Radiological evidence of resolution of fatty marrow after bone marrow transplantation.
   Br J Haematol. 2022 Feb 22. doi: 10.1111/bjh.18068.
   

   >> Share

   
   November 2021
10. ABEDIN S, Rashid N, Schroeder M, Romee R, et al
    Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.
    Br J Haematol. 2021;195:429-432.
    

    >> Share

    
    August 2021
11. LUCCHINI G, Furness C, Lawson S, Gibson B, et al
    COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience.
    Br J Haematol. 2021;194:e74-e77.
    

    >> Share

    
    July 2021
12. WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
    The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
    Br J Haematol. 2021;194:e56-e58.
    

    >> Share

    
    May 2021
13. CHANDER G, Nikolousis E, Kanellopoulos A
    Human papilloma virus (HPV)-associated lesions in a post-bone marrow transplant patient responding to HPV vaccination.
    Br J Haematol. 2021 May 2. doi: 10.1111/bjh.17514.
    

    >> Share

    
    April 2021
14. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    

    >> Share

    
    
15. SIMINI G, Mackenzie S, Gohil S, Papanikolaou X, et al
    Successful use of allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome presenting with autoimmune manifestations.
    Br J Haematol. 2021 Apr 11. doi: 10.1111/bjh.17437.
    

    >> Share

    
    
16. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    

    >> Share

    
    
17. YUASA M, Asano-Mori Y, Mitsuki T, Yamaguchi K, et al
    Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation.
    Br J Haematol. 2021;193:423-427.
    

    >> Share

    
    March 2021
18. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    

    >> Share

    
    November 2020
19. BARRETT J, Craddock C
    Bone marrow transplantation in the United Kingdom - past, present and future.
    Br J Haematol. 2020;191:612-616.
    

    >> Share

    
    October 2020
20. SMITH G, Apperley J, Milojkovic D, Cross NCP, et al
    A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.
    Br J Haematol. 2020;191:171-193.
    

    >> Share

    
    June 2020
21. RASHIDI A, Herman A, Gomes ALC, Peled JU, et al
    An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease.
    Br J Haematol. 2020;189:926-930.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share